vs
Side-by-side financial comparison of AstroNova, Inc. (ALOT) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
AstroNova, Inc. is the larger business by last-quarter revenue ($39.2M vs $31.1M, roughly 1.3× LIFECORE BIOMEDICAL, INC. \DE\). AstroNova, Inc. runs the higher net margin — 1.0% vs -32.1%, a 33.1% gap on every dollar of revenue. On growth, AstroNova, Inc. posted the faster year-over-year revenue change (-3.4% vs -4.5%). AstroNova, Inc. produced more free cash flow last quarter ($3.3M vs $25.0K). Over the past eight quarters, AstroNova, Inc.'s revenue compounded faster (2.1% CAGR vs -0.1%).
AstroNova, Inc. is a global technology firm designing, manufacturing and distributing specialty data visualization products, including high-performance label printers, test and measurement equipment, and aerospace-grade data recording systems, serving aerospace, manufacturing, retail and healthcare markets worldwide.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
ALOT vs LFCR — Head-to-Head
Income Statement — Q3 FY2026 vs Q2 FY2026
| Metric | ||
|---|---|---|
| Revenue | $39.2M | $31.1M |
| Net Profit | $378.0K | $-10.0M |
| Gross Margin | 36.2% | 25.0% |
| Operating Margin | 3.3% | -9.9% |
| Net Margin | 1.0% | -32.1% |
| Revenue YoY | -3.4% | -4.5% |
| Net Profit YoY | 221.5% | -52.0% |
| EPS (diluted) | $0.05 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.2M | — | ||
| Q3 25 | $36.1M | $31.1M | ||
| Q2 25 | $37.7M | — | ||
| Q1 25 | — | $35.2M | ||
| Q4 24 | $40.4M | $32.6M | ||
| Q3 24 | $40.5M | $24.7M | ||
| Q2 24 | $33.0M | — | ||
| Q1 24 | $39.6M | $35.7M |
| Q4 25 | $378.0K | — | ||
| Q3 25 | $-1.2M | $-10.0M | ||
| Q2 25 | $-376.0K | — | ||
| Q1 25 | — | $-14.8M | ||
| Q4 24 | $240.0K | $-6.6M | ||
| Q3 24 | $-311.0K | $-16.2M | ||
| Q2 24 | $1.2M | — | ||
| Q1 24 | $2.7M | $15.6M |
| Q4 25 | 36.2% | — | ||
| Q3 25 | 32.2% | 25.0% | ||
| Q2 25 | 33.6% | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | 33.9% | 34.0% | ||
| Q3 24 | 35.3% | 21.8% | ||
| Q2 24 | 36.3% | — | ||
| Q1 24 | 31.9% | 33.3% |
| Q4 25 | 3.3% | — | ||
| Q3 25 | -2.0% | -9.9% | ||
| Q2 25 | 1.5% | — | ||
| Q1 25 | — | -25.7% | ||
| Q4 24 | 3.1% | -6.0% | ||
| Q3 24 | 2.6% | -46.9% | ||
| Q2 24 | 4.1% | — | ||
| Q1 24 | 9.9% | -2.5% |
| Q4 25 | 1.0% | — | ||
| Q3 25 | -3.4% | -32.1% | ||
| Q2 25 | -1.0% | — | ||
| Q1 25 | — | -42.0% | ||
| Q4 24 | 0.6% | -20.2% | ||
| Q3 24 | -0.8% | -65.7% | ||
| Q2 24 | 3.6% | — | ||
| Q1 24 | 6.8% | 43.8% |
| Q4 25 | $0.05 | — | ||
| Q3 25 | $-0.16 | $-0.29 | ||
| Q2 25 | $-0.05 | — | ||
| Q1 25 | — | $-0.47 | ||
| Q4 24 | $0.03 | $-0.25 | ||
| Q3 24 | $-0.04 | $-0.53 | ||
| Q2 24 | $0.15 | — | ||
| Q1 24 | $0.37 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $76.9M | $-10.5M |
| Total Assets | $140.8M | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.6M | — | ||
| Q3 25 | $3.9M | $18.9M | ||
| Q2 25 | $5.4M | — | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | $4.4M | $9.5M | ||
| Q3 24 | $4.8M | — | ||
| Q2 24 | $4.0M | — | ||
| Q1 24 | $4.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $76.9M | — | ||
| Q3 25 | $75.8M | $-10.5M | ||
| Q2 25 | $76.6M | — | ||
| Q1 25 | — | $2.2M | ||
| Q4 24 | $92.2M | $15.4M | ||
| Q3 24 | $91.8M | $-3.9M | ||
| Q2 24 | $91.2M | — | ||
| Q1 24 | $90.3M | $17.7M |
| Q4 25 | $140.8M | — | ||
| Q3 25 | $143.1M | $235.2M | ||
| Q2 25 | $150.3M | — | ||
| Q1 25 | — | $237.7M | ||
| Q4 24 | $166.5M | $255.4M | ||
| Q3 24 | $169.0M | $246.8M | ||
| Q2 24 | $126.6M | — | ||
| Q1 24 | $133.3M | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $3.4M | $1.8M |
| Free Cash FlowOCF − Capex | $3.3M | $25.0K |
| FCF MarginFCF / Revenue | 8.5% | 0.1% |
| Capex IntensityCapex / Revenue | 0.2% | 5.6% |
| Cash ConversionOCF / Net Profit | 9.05× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.9M | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.4M | — | ||
| Q3 25 | $249.0K | $1.8M | ||
| Q2 25 | $4.4M | — | ||
| Q1 25 | — | $1.2M | ||
| Q4 24 | $-4.7M | $-6.1M | ||
| Q3 24 | $162.0K | $-613.0K | ||
| Q2 24 | $6.9M | — | ||
| Q1 24 | $6.5M | $-1.4M |
| Q4 25 | $3.3M | — | ||
| Q3 25 | $202.0K | $25.0K | ||
| Q2 25 | $4.3M | — | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | $-5.0M | $-8.6M | ||
| Q3 24 | $-176.0K | $-4.0M | ||
| Q2 24 | $6.4M | — | ||
| Q1 24 | $6.0M | $-7.8M |
| Q4 25 | 8.5% | — | ||
| Q3 25 | 0.6% | 0.1% | ||
| Q2 25 | 11.5% | — | ||
| Q1 25 | — | -12.1% | ||
| Q4 24 | -12.4% | -26.3% | ||
| Q3 24 | -0.4% | -16.3% | ||
| Q2 24 | 19.5% | — | ||
| Q1 24 | 15.3% | -21.8% |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.1% | 5.6% | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | 0.6% | 7.5% | ||
| Q3 24 | 0.8% | 13.9% | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 1.0% | 17.8% |
| Q4 25 | 9.05× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -19.76× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.85× | — | ||
| Q1 24 | 2.38× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALOT
| Public Utilities Inventory Supplies | $20.6M | 53% |
| Hardware Products | $12.7M | 32% |
| Service And Other | $5.9M | 15% |
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |